13F HOLDINGS REPORT
JOHNSON & JOHNSON
Quarter ended Q4 2023 · Filed November 9, 2023 · Accession 0000904454-23-000600
Total Value
$271.5M
Positions
24
Other Managers
1
Confidential Omitted
No
Holdings (24)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Legend Biotech Corporation | LEGN | 814,586 | $54.7M | 20.16% |
| 2 | CVRx, Inc. | CVRX | 3,495,575 | $53.0M | 19.53% |
| 3 | Protagonist Therapeutics Inc. | PTGX | 2,449,183 | $40.9M | 15.05% |
| 4 | MeiraGTx Holdings plc | MGTX | 6,641,064 | $32.6M | 12.01% |
| 5 | Xencor, Inc. | XNCR | 748,062 | $15.1M | 5.55% |
| 6 | Neumora Therapeutics, Inc. | NMRA | 912,128 | $12.9M | 4.74% |
| 7 | Procept BioRobotics Corporation | PRCT | 357,939 | $11.7M | 4.33% |
| 8 | Fusion Pharmaceuticals Inc. | 36118A100 | 3,670,516 | $9.5M | 3.52% |
| 9 | Nanobiotix S.A. | NBTX | 959,637 | $8.4M | 3.09% |
| 10 | Fate Therapeutics, Inc. | FATE | 3,379,064 | $7.2M | 2.64% |
| 11 | Point Biopharma Global Inc. | 730541109 | 1,000,000 | $6.7M | 2.46% |
| 12 | Arrowhead Pharmaceuticals, Inc. | ARWR | 247,598 | $6.7M | 2.45% |
| 13 | Aldeyra Therapeutics, Inc. | ALDX | 394,834 | $2.6M | 0.97% |
| 14 | Cue Health, Inc. | 229790100 | 5,548,864 | $2.5M | 0.90% |
| 15 | Vor Biopharma, Inc. | VOR | 1,074,658 | $2.3M | 0.84% |
| 16 | Nano-X Imaging Ltd. | NNOX | 317,704 | $2.1M | 0.77% |
| 17 | Adicet Bio, Inc. | ACET | 728,944 | $998,653 | 0.37% |
| 18 | BiomX Inc. | PHGE | 2,133,402 | $750,958 | 0.28% |
| 19 | SomaLogic, Inc. | 83444K105 | 281,052 | $671,714 | 0.25% |
| 20 | Clearside Biomedical, Inc. | CLSDQ | 169,629 | $147,560 | 0.05% |
| 21 | Apollomics, Inc. | APLMW | 13,252 | $49,629 | 0.02% |
| 22 | Senseonics Holdings, Inc. | SENS | 54,621 | $32,986 | 0.01% |
| 23 | Catalyst Biosciences, Inc. | 14888D208 | 66,951 | $32,290 | 0.01% |
| 24 | Tracon Pharmaceuticals, Inc. | 89237H209 | 84,003 | $14,953 | 0.01% |